The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats
Haris Carageorgiou1, Antonios C Sideris1, Ioanna Messari1, Chrissoula I Liakou1, Stylianos Tsakiris21Department of Pharmacology, 2Department of Physiology, Medical School, University of Athens, Athens, GreeceAbstract: We investigated the effects of rivastigmine (a cholinesterase inhibitor) and seleg...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b6f106d167f247ba98ab073ab0968dd3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b6f106d167f247ba98ab073ab0968dd3 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b6f106d167f247ba98ab073ab0968dd32021-12-02T08:06:18ZThe effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats1176-63281178-2021https://doaj.org/article/b6f106d167f247ba98ab073ab0968dd32008-09-01T00:00:00Zhttp://www.dovepress.com/the-effects-of-rivastigmine-plus-selegiline-on-brain-acetylcholinester-a2192https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Haris Carageorgiou1, Antonios C Sideris1, Ioanna Messari1, Chrissoula I Liakou1, Stylianos Tsakiris21Department of Pharmacology, 2Department of Physiology, Medical School, University of Athens, Athens, GreeceAbstract: We investigated the effects of rivastigmine (a cholinesterase inhibitor) and selegiline ((-)deprenyl, an irreversible inhibitor of monoamineoxidase-B), alone and in combination, on brain acetylcholinesterase (AChE), (Na+, K+)-, Mg2+-ATPase activities, total antioxidant status (TAS), and learning performance, after long-term drug administration in aged male rats. The possible relationship between the biochemical and behavioral parameters was evaluated.Methods: Aged rats were treated (for 36 days) with rivastigmine (0.3 mg/kg rat/day ip), selegiline (0.25 mg/kg rat/day im), rivastigmine plus selegiline in the same doses and way of administration as separately. Aged and adult control groups received NaCl 0.9% 0.5 ml ip.Results: TAS was lower in aged than in adult rats, rivastigmine alone does not affect TAS, decreases AChE activity, increases (Na+, K+)-ATPase and Mg2+-ATPase activity of aged rat brain and improves cognitive performance. Selegiline alone decreases free radical production and increases AChE activity and (Na+, K+)-ATPase activity, improving cognitive performance as well. In the combination: rivastigmine seems to cancel selegiline action on TAS and AChE activity, while it has additive effect on (Na+, K+)-ATPase activity. In the case of Mg2+-ATPase selegiline appears to attenuate rivastigmine activity. No statistically significant difference was observed in the cognitive performance.Conclusion: Reduced TAS, AChE activity and learning performance was observed in old rats. Both rivastigmine and selesiline alone improved performance, although they influenced the biochemical parameters in a different way. The combination of the two drugs did not affect learning performance.Keywords: aged rat, brain enzymes, TAS, learning, rivastigmine, selegiline Haris CarageorgiouAntonios C SiderisIoanna MessariChrissoula I LiakouStylianos TsakirisDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 4, Pp 687-699 (2008) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Haris Carageorgiou Antonios C Sideris Ioanna Messari Chrissoula I Liakou Stylianos Tsakiris The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats |
| description |
Haris Carageorgiou1, Antonios C Sideris1, Ioanna Messari1, Chrissoula I Liakou1, Stylianos Tsakiris21Department of Pharmacology, 2Department of Physiology, Medical School, University of Athens, Athens, GreeceAbstract: We investigated the effects of rivastigmine (a cholinesterase inhibitor) and selegiline ((-)deprenyl, an irreversible inhibitor of monoamineoxidase-B), alone and in combination, on brain acetylcholinesterase (AChE), (Na+, K+)-, Mg2+-ATPase activities, total antioxidant status (TAS), and learning performance, after long-term drug administration in aged male rats. The possible relationship between the biochemical and behavioral parameters was evaluated.Methods: Aged rats were treated (for 36 days) with rivastigmine (0.3 mg/kg rat/day ip), selegiline (0.25 mg/kg rat/day im), rivastigmine plus selegiline in the same doses and way of administration as separately. Aged and adult control groups received NaCl 0.9% 0.5 ml ip.Results: TAS was lower in aged than in adult rats, rivastigmine alone does not affect TAS, decreases AChE activity, increases (Na+, K+)-ATPase and Mg2+-ATPase activity of aged rat brain and improves cognitive performance. Selegiline alone decreases free radical production and increases AChE activity and (Na+, K+)-ATPase activity, improving cognitive performance as well. In the combination: rivastigmine seems to cancel selegiline action on TAS and AChE activity, while it has additive effect on (Na+, K+)-ATPase activity. In the case of Mg2+-ATPase selegiline appears to attenuate rivastigmine activity. No statistically significant difference was observed in the cognitive performance.Conclusion: Reduced TAS, AChE activity and learning performance was observed in old rats. Both rivastigmine and selesiline alone improved performance, although they influenced the biochemical parameters in a different way. The combination of the two drugs did not affect learning performance.Keywords: aged rat, brain enzymes, TAS, learning, rivastigmine, selegiline |
| format |
article |
| author |
Haris Carageorgiou Antonios C Sideris Ioanna Messari Chrissoula I Liakou Stylianos Tsakiris |
| author_facet |
Haris Carageorgiou Antonios C Sideris Ioanna Messari Chrissoula I Liakou Stylianos Tsakiris |
| author_sort |
Haris Carageorgiou |
| title |
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats |
| title_short |
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats |
| title_full |
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats |
| title_fullStr |
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats |
| title_full_unstemmed |
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats |
| title_sort |
effects of rivastigmine plus selegiline on brain acetylcholinesterase, (na+, k+)-, mg2+-atpase activities, antioxidant status, and learning performance of aged rats |
| publisher |
Dove Medical Press |
| publishDate |
2008 |
| url |
https://doaj.org/article/b6f106d167f247ba98ab073ab0968dd3 |
| work_keys_str_mv |
AT hariscarageorgiou theeffectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT antonioscsideris theeffectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT ioannamessari theeffectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT chrissoulailiakou theeffectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT stylianostsakiris theeffectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT hariscarageorgiou effectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT antonioscsideris effectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT ioannamessari effectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT chrissoulailiakou effectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats AT stylianostsakiris effectsofrivastigmineplusselegilineonbrainacetylcholinesterasenaampnbspkmg2atpaseactivitiesantioxidantstatusandlearningperformanceofagedrats |
| _version_ |
1718398682412351488 |